Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Mantle-Cell

Explore clinical trials studying Lymphoma, Mantle-Cell. Study availability and eligibility vary by location and protocol.

889 public trials 111 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Mantle-Cell trial results

Completed

A Study to Determine the Efficacy and Safety of Lenalidomide in Patients With Mantle Cell NHL Who Have Relapsed or Progressed After Treatment With Bortezomib or Are Refractory to Bortezomib. The "EMERGE" Trial

NCT00737529

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • UCSD Moores Cancer Center La Jolla, California, United States
  • Loma Linda University Medical Center Loma Linda, California, United States
  • Tower Cancer Research Foundation Los Angeles, California, United States
View all 70 locations
View Trial Details
Completed

Bortezomib, Rituximab, Cyclophosphamide, and Prednisone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma

NCT00295932

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +27 more
Locations
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • Memorial Sloan-Kettering at Basking Ridge Basking Ridge, New Jersey, United States
  • Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School New Brunswick, New Jersey, United States
  • Memorial Sloan-Kettering Cancer Center @ Suffolk Commack, New York, United States
View Trial Details
Completed

Phase III, Multicentre, Randomised Study of Fludarabine/Cyclophosphamide Combination With or Without Rituximab in Patients With Untreated Mantle Cell Lymphoma

NCT00641095

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Peter MacCallum Cancer Centre East Melbourne, Victoria, Australia
  • William Harvey Hospital Ashford, England, United Kingdom
  • Stoke Mandeville Hospital Aylesbury, England, United Kingdom
  • Basingstoke and North Hampshire NHS Foundation Trust Basingstoke, England, United Kingdom
View all 67 locations
View Trial Details
Completed

Bortezomib and Lenalidomide in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

NCT00553644

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Kaiser Permanente-Anaheim Anaheim, California, United States
  • Kaiser Permanente-Baldwin Park Baldwin Park, California, United States
  • Kaiser Permanente-Bellflower Bellflower, California, United States
  • Kaiser Permanente-Fontana Fontana, California, United States
View all 82 locations
View Trial Details

Related conditions